pergolide mesylate , a dopamine agonist , was studied as adjunctive therapy in a 6-month double-blind trial in 20 patients with parkinson 's disease who were achieving less than optimal response from sinemet .
C0031008
pergolide mesylate
C0030567
parkinson 's disease